Glioma

News Glioma

• Neural Precursor Cells Induce Cell Death in Certain Brain Tumors

  Neural precursor cells (NPC) in the young brain suppress certain brain tumors such as high-grade gliomas, especially glioblastoma (GBM), which are among the most common and most aggressive tumors. Now researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité – Unive more

• e-Therapeutics’ ETS2101 enters phase I clinical trial in brain cancer

  e-Therapeutics plc announces the start of the first clinical trial evaluating its compound ETS2101 as a treatment for cancer. The phase I trial is enrolling patients with primary brain cancer (glioma) or cancer that has spread to the brain from other sites. Led by Professor Santosh Kesari, MD, PhD, more

• Specialised Therapeutics to license brain tumor visualisation drug Gliolan in Australia and New Zealand

  A new drug which aids neurosurgeons to better visualise and operate on brain tumours that have a poor prognosis, high grade gliomas, will be available in Australia under a special access program later this year. Specialised Therapeutics Australia Ltd has signed a binding term sheet with German compa more

Publications Glioma

• [Report] An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells

  A small molecule that inhibits a mutant enzyme in tumors slows malignant growth by inducing cancer cell differentiation. [Also see Perspective by Kim and DeBerardinis] more

• Integration of epidemiology, immunobiology, and translational research for brain tumors

  We recently identified a pivotal role for the host type I interferon (IFN) pathway in immunosurveillance against de novo mouse glioma development, especially through the regulation of immature myeloid cells (IMCs) in the glioma microenvironment. The present paper summarizes our published work in a more

• Molecular definition of the pro‐tumorigenic phenotype of glioma‐activated microglia

  Microglia are myeloid cells residing in the central nervous system that participate in inflammatory responses and could promote injury and repair. Gliomas attract microglia and polarize them into tumor‐supporting cells that participate in matrix remodeling, invasion, angiogenesis, and suppression more

Market studies Glioma

• Adult Malignant Glioma – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Adult Malignant Glioma - Pipeline Review, H1 2012', provides an overview of the Adult Malignant Glioma therapeutic pipeline. This report provides information on the therapeutic development for Adult Malignant Glioma, complete with latest updates, and special more

• Glioma – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Glioma - Pipeline Review, H1 2012', provides an overview of the Glioma therapeutic pipeline. This report provides information on the therapeutic development for Glioma, complete with latest updates, and special features on late-stage and discontinued projects. more

• Recurrent Malignant Glioma – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Recurrent Malignant Glioma - Pipeline Review, H2 2012', provides an overview of the Recurrent Malignant Glioma therapeutic pipeline. This report provides information on the therapeutic development for Recurrent Malignant Glioma, complete with latest updates, more

Websites Glioma